Effect of Biological Disease Modifying Anti Rheumatic Drug (bDMARD) Treatment on Spinal Fracture Incidence in Patients With Ankylosing Spondylitis (AS)
CompletedOBSERVATIONAL
Enrollment
9,858
Participants
Timeline
Start Date
January 31, 2005
Primary Completion Date
December 31, 2015
Study Completion Date
October 24, 2017
Conditions
Ankylosing SpondylitisSpinal Fractures
Interventions
DRUG
bDMARD treatment
Treatment with bDMARD includes registered ATC-codes: L04AA and L04AB.
All Listed Sponsors
lead
Uppsala University
OTHER
NCT02840695 - Effect of Biological Disease Modifying Anti Rheumatic Drug (bDMARD) Treatment on Spinal Fracture Incidence in Patients With Ankylosing Spondylitis (AS) | Biotech Hunter | Biotech Hunter